Evaluating Alcohol Use in Alcoholic Liver Disease

Status Recruiting

Clinical Trial Summary

This prospective, analytic observational study will investigate alcohol recidivism in patients with alcoholic liver disease. All adult subjects presenting with alcoholic liver disease are considered for inclusion. Subjects able to give consent are included.

Clinical Trial Description

This is a longitudinal observational study. Subjects with a diagnosis of alcoholic liver disease (acute alcoholic hepatitis or alcoholic cirrhosis) who present to Weill Cornell Medical Center or Columbia University Medical Center New York Presbyterian Hospital or the Gastroenterology and Hepatology Clinic will be invited to join this study, which entails a survey at baseline and follow-up at 3, 6, 9, 12, 15, and 18 months and then at 2, 5, and 10 years. Follow-up will consist of a chart review, a phone or in person interview, and most recent clinic visit interview for alcohol recidivism. The clinical providers will be blinded to the survey results. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03267069
Study type	Observational [Patient Registry]
Source	New York Presbyterian Hospital
Contact	Nicole T Shen, MD
Phone	3146095911
Email	nts9004@nyp.org
Status	Recruiting
Phase
Start date	November 27, 2016
Completion date	November 1, 2027

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00708617` - FIBROSCAN Validation and Interest of Fibrotest - FIBROSCAN Association for Fibrosis Diagnosis in Alcoholic Liver Disease	N/A
Completed	`NCT00990639` - Effect of Candesartan in Alcoholic Liver Fibrosis	Phase 1/Phase 2
Recruiting	`NCT04106518` - Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease
Recruiting	`NCT04666402` - Integrated Diagnostics for Early Diagnosis of Liver Disease
Recruiting	`NCT02331745` - RCT Study on Granulocyte Colony-stimulating Factor(G-CSF) Treatment of Hepatic Failure	Phase 4
Completed	`NCT01501162` - Effect of Probiotics on Gut-Liver Axis of Alcoholic Liver Disease	Phase 4
Recruiting	`NCT05895890` - French National MICMAF Cohort
Completed	`NCT04557774` - Cognitive Function of Alcoholic Compensated Liver Cirrhosis
Recruiting	`NCT03295812` - Stratification of Chronic Alcoholic Liver Diseases (SCALE Study)	N/A
Recruiting	`NCT05855031` - The Liver Care Trial	N/A
Not yet recruiting	`NCT03503708` - Herbal Supplements for Improvement of Liver Function in Participants With Alcoholic Liver Disease	N/A
Completed	`NCT02796469` - Meta-Analysis of Drug Therapy in Patients With Severe Alcoholic Hepatitis	N/A
Completed	`NCT02140294` - Long Term Effect of Aggressive Nutritional Management on Survival in Patients With Alcoholic Liver Disease	N/A
Recruiting	`NCT03209791` - Ethanol Induces Skeletal Muscle Autophagy
Recruiting	`NCT04736966` - Guselkumab (Anti-IL 23 Monoclonal Antibody) for Alcohol Associated Liver Disease	Phase 1
Recruiting	`NCT04400604` - Study of Alcohol-related Liver Disease in Europe
Completed	`NCT03402256` - Text Messaging to Reduce Alcohol Relapse in Liver Transplant Patients	N/A
Completed	`NCT01711125` - Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease	Phase 3
Active, not recruiting	`NCT03863730` - Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic Microbiota	N/A
Not yet recruiting	`NCT06307964` - Intra-Hepatic Microbiota in Alcoholic Hepatitis